Sugary Beverages Linked to disruption in salivary microbiome: StudyA recent study published in the journal Scientific Reports ...

Experts share what you need to know about the artificial sweetener.

About Chiesi Group Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty ...

People with type 2 diabetes show improvement following oral semaglutide treatment Stem cell therapy cures man with type 2 ...

Sumitomo Pharma America, Inc. (SMPA) today announced the oral presentation of data from the ongoing Phase 1/2 first-in-human study of DSP-5336 in patients with relapsed or refractory acute leukemia at ...

Vitamin D extended the lifespan of killifish, a recent study found, suggesting the vitamin could have similar effects in ...

Farxiga (dapagliflozin) has been approved by the FDA to treat type-2 diabetes patients ages 10 and older, AstraZeneca ...

The Pat Summitt Foundation (PSF) in collaboration with University of Tennessee Extension Family and Consumer Sciences, is ...

Lilly’s past is deeply tied to diabetes, having been the first company to sell insulin after it licensed a patent from ...

Farxiga, a first-in-class, oral, once-daily sodium-glucose cotransporter 2 (SGLT2 ... as add-on treatment in children and adolescents with T2D receiving metformin, insulin or both. Patients were ...

Many members of DiabetesTeam have wondered about how magnesium levels relate to diabetes. One member commented, "I got a phone call from my doctor's office. My magnesium is still too low, and I have ...